Abstract:A new synthetic route to N-Cbz-cis-(3R,4R)-3-methylamino-4-methylpiperidine, key intermediate for CP-690,550, was disclosed with L-malic acid as the chiral pool starting material. The title compound was obtained in 16 steps with a total yield of 26% and more than 98% ee.
“…An alternative method employs l ‐malic acid ( 45 ) as the chiral pool starting material, to attain the Cbz‐protected compound 52 (Scheme ) . Despite the extensive synthetic sequence (16 steps), the authors claim that the synthetic sequence possessed several advantages, such as cheap raw materials, mild reaction conditions and an overall yield of 26 % yielding the product 54 with > 98 % ee .…”
Section: Assembly Of the Piperidine Moietymentioning
Tofacitinib is a Janus activated kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis and active psoriatic arthritis. Its synthesis normally involves long synthetic sequences due to the chirality associated to the piperidine ring. This review is a comprehensive analysis of the different synthetic methods used to prepare this active pharmaceutical ingredient (API), covering the related journal and patent literature.
“…An alternative method employs l ‐malic acid ( 45 ) as the chiral pool starting material, to attain the Cbz‐protected compound 52 (Scheme ) . Despite the extensive synthetic sequence (16 steps), the authors claim that the synthetic sequence possessed several advantages, such as cheap raw materials, mild reaction conditions and an overall yield of 26 % yielding the product 54 with > 98 % ee .…”
Section: Assembly Of the Piperidine Moietymentioning
Tofacitinib is a Janus activated kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis and active psoriatic arthritis. Its synthesis normally involves long synthetic sequences due to the chirality associated to the piperidine ring. This review is a comprehensive analysis of the different synthetic methods used to prepare this active pharmaceutical ingredient (API), covering the related journal and patent literature.
Title compound (II), key building block for the synthesis of the first‐in‐class Janas tyrosine kinase inhibitor CP‐690,550, is prepared from cheap raw materials using established transformations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.